LifeStance Health (LFST) Change in Receivables (2020 - 2026)

LifeStance Health (LFST) has 7 years of Change in Receivables data on file, last reported at $27.0 million in Q1 2026.

• Change in Receivables for Q1 2026 came in at $27.0 million, up 214.58% year-over-year; the trailing twelve-month figure through Mar 2026 was -$17.7 million (up 50.22% YoY), and the FY2025 annual result was -$36.1 million, down 664.2% from the prior year.
• Change in Receivables improved to $27.0 million in Q1 2026 per LFST's latest filing, from -$25.4 million in the prior quarter.
• Over five years, Change in Receivables peaked at $50.5 million in Q1 2024 and troughed at -$26.4 million in Q4 2024.
• A 5-year average of $2.5 million and a median of $3.4 million in 2023 frame the typical range for Change in Receivables.
• On a YoY basis, Change in Receivables climbed as much as 481.55% in 2022 and fell as far as 469.59% in 2022.
• A 5-year view of Change in Receivables shows it stood at -$12.9 million in 2022, then slumped by 87.82% to -$24.3 million in 2023, then retreated by 8.44% to -$26.4 million in 2024, then rose by 3.78% to -$25.4 million in 2025, then surged by 206.27% to $27.0 million in 2026.
• Business Quant data shows LFST's Change in Receivables at $27.0 million in Q1 2026, -$25.4 million in Q4 2025, and -$8.4 million in Q3 2025.